Gene microarray analysis of the lncRNA expression profile in human urothelial carcinoma of the bladder

International Journal of Clinical and Experimental Medicine

Volumn 7, Issue 5, 2014, Pages 1244-1254

  Luo, Huarong ^a   Zhao, Xin ^a   Wan, Xiaodong ^a   Huang, Shengsong ^a   Wu, Denglong ^a  

^a TONGJI HOSPITAL OF TONGJI UNIVERSITY   (China)

Author keywords

Expression profile; Gene microarray; LncRNA; Urinary bladder; Urothelial carcinoma

Indexed keywords

LONG UNTRANSLATED RNA; RNA 18S; RNA 28S;

ARTICLE; BLADDER CANCER; CHROMOSOME 1; CHROMOSOME 2; CHROMOSOME 3; CHROMOSOME 4; CHROMOSOME 6; CONTROLLED STUDY; DENATURING GRADIENT GEL ELECTROPHORESIS; DNA HYBRIDIZATION; DOWN REGULATION; GENE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; TRANSITIONAL CELL CARCINOMA; UPREGULATION; X CHROMOSOME;

EID: 84902184078     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Karim Kader. Bladder Cancer. ScientificWorldJournal 2011; 11: 2565-2566.
2. Braisch U, Meyer M, Radespiel-Tröger M. Risk of tobacco-related multiple primary cancers in Bavaria. Germany BMC Cancer 2012; 12: 250.
3. Burger M, Catto JW, Dalbagni G, Grossman HB, Herr H, Karakiewicz P, Kassouf W, Kiemeney LA, La Vecchia C, Shariat S, Lotan Y. Epidemiology and Risk Factors of Urothelial Bladder Cancer. Eur Urol 2013; 63: 234-241.
4. Reinert T. Methylation Markers for Urine-Based Detection of Bladder Cancer: The Next Generation of Urinary Markers for Diagnosis and Surveillance of Bladder Cancer. Adv Urol 2012; 6: 503271.
5. Santoni M, Catanzariti F, Minardi D, Burattini L, Nabissi M, Muzzonigro G, Cascinu S, Santoni G. Pathogenic and Diagnostic Potential of BLCA1 and BLCA4 Nuclear Proteins in Urothelial Cell Carcinoma of Human Bladder. Adv Urol 2012; 7: 397412.
6. Lee H, Choi SK, Ro JY. Overexpression of DJ-1 and HSP90α, and loss of PTEN associated with invasive urothelial carcinoma of urinary bladder: Possible prognostic markers. Oncol Lett 2012; 3: 507-512.
7. Urquidi V, Kim J, Chang M, Dai Y, Rosser CJ, Goodison S. CCL18 in a multiplex urine-based assay for the detection of bladder cancer. PLoS One 2012; 7: 37797.
8. Zhao P, Liu C, Xu K, Zheng S, Li H, Xu Y, Xu A, Li B, Huang P. Expression of OCT4 protein in bladder cancer and its clinicopathological implications. Nan Fang Yi Ke Da Xue Xue Bao 2012; 32: 643-646.
9. Thanan R, Murata M, Ma N, Hammam O, Wishahi M, El Leithy T, Hiraku Y, Oikawa S, Kawanishi S. Nuclear localization of COX-2 in relation to the expression of stemness markers in urinary bladder cancer. Mediators Inflamm 2012; 4: 165879.
10. Urquidi V, Chang M, Dai Y, Kim J, Wolfson ED, Goodison S, Rosser CJ. IL 8 as a urinary biomarker for the detection of bladder cancer. BMC Urol 2012; 4: 12.
11. Johnen G, Gawrych K, Bontrup H, Pesch B, Taeger D, Banek S, Kluckert M, Wellhäußer H, Eberle F, Nasterlack M, Leng G, Stenzl A, Brüning T; UroScreen Study Group. Performance of survivin mRNA as a biomarker for bladder cancer in the prospective study UroScreen. PLoS One 2012; 7: 35363.
12. Fu YP, Kohaar I, Rothman N, Earl J, Figueroa JD, Ye Y, Malats N, Tang W, Liu L, Garcia-Closas M, Muchmore B, Chatterjee N, Tarway M, Kogevinas M, Porter-Gill P, Baris D, Mumy A, Albanes D, Purdue MP, Hutchinson A, Carrato A, Tardón A, Serra C, García-Closas R, Lloreta J, Johnson A, Schwenn M, Karagas MR, Schned A, Diver WR, Gapstur SM, Thun MJ, Virtamo J, Chanock SJ, Fraumeni JF Jr, Silverman DT, Wu X, Real FX, Prokunina-Olsson L. Common genetic variants in the PSCA gene influence gene expression and bladder cancer risk. Proc Natl Acad Sci U S A 2012; 109: 4974-4979.
13. El Gehani K, Al-Kikhia L, Emaetig F, Syrjänen K, Al-Fituri O, Elzagheid A. Over-expression of HER-2 is associated with the stage in carcinomas of the urinary bladder. Libyan J Med 2012; 7: 14694.
14. Hosseini J, Golshan AR, Mazloomfard MM, Mehrsai AR, Zargar MA, Ayati M, Shakeri S, Jasemi M, Kabiri M. Detection of recurrent bladder cancer: NMP22 test or urine cytology. Urol J 2012; 9: 367-372.
15. Feng CC, Wang PH, Guan M, Jiang HW, Wen H, Ding Q, Wu Z. Urinary BLCA-4 is highly specific for detection of bladder cancer in Chinese Han population and is related to tumour invasiveness. Folia Biol (Praha) 2011; 57: 242-247.
16. Choi W, Shah JB, Tran M, Svatek R, Marquis L, Lee IL, Yu D, Adam L, Wen S, Shen Y, Dinney C, McConkey DJ, Siefker-Radtke A. p63 expression defines a lethal subset of muscle-invasive bladder cancers. PLoS One 2012; 7: 30206.
17. Kim TS, Rhew HY, Hwang HY. Pilot study of the clinical significance of serum and urinary her-2/neu protein in bladder cancer patients. Korean J Urol 2011; 52: 815-818.
18. Ewald F, Ueffing N, Brockmann L, Hader C, Telieps T, Schuster M, Schulz WA, Schmitz I. The role of c-FLIP splice variants in urothelial tumours. Cell Death Dis 2011; 22: 245.
19. Gibb EA, Brown CJ, Lam WL. The functional role of long non-coding RNA in human carcinomas. Mol Cancer 2011; 13: 38.
20. Orom UA, Derrien T, Beringer M, Gumireddy K, Gardini A, Bussotti G, Lai F, Zytnicki M, Notredame C, Huang Q, Guigo R, Shiekhattar R. Long noncoding RNAs with enhancer-like function in human cells. Cell 2010; 143: 46-58.
21. Bian S, Sun T. Functions of noncoding RNAs in neural development and neurological diseases. Mol Neurobiol 2011; 44: 359-373.
22. Gibb EA, Vucic EA, Enfield KS, Stewart GL, Lonergan KM, Kennett JY, Becker-Santos DD, MacAulay CE, Lam S, Brown CJ, Lam WL. Human cancer long non-coding RNA transcriptomes. PLoS One 2011; 6: 5915-5917.
23. Zhu Y, Yu M, Li Z, Kong C, Bi J, Li J, Gao Z, Li Z. ncRAN, a newly identified long noncoding RNA, enhances human bladder tumor growth, invasion, and survival. Urology 2011; 77: 510-515.
24. Panzeri E, Conconi D, Antolini L, Redaelli S, Valsecchi MG, Bovo G, Pallotti F, Viganò P, Strada G, Dalprà L, Bentivegna A. Chromosomal aberrations in bladder cancer: fresh versus formalin fixed paraffin embedded tissue and targeted FISH versus wide microarray-based CGH analysis. PLoS One 2011; 6: 24237.
25. Minner S, Kilgué A, Stahl P, Weikert S, Rink M, Dahlem R, Fisch M, Höppner W, Wagner W, Bokemeyer C, Terracciano L, Simon R, Sauter G, Wilczak W. Y chromosome loss is a frequent early event in urothelial bladder cancer. Pathology 2010; 42: 356-359.
26. Zieger K, Wiuf C, Jensen KM, Orntoft TF, Dyrskjot L. Chromosomal imbalance in the progression of high-risk non-muscle invasive bladder cancer. BMC Cancer 2009; 16: 149.
27. Wang XS, Zhang Z, Wang HC, Cai JL, Xu QW, Li MQ, Chen YC, Qian XP, Lu TJ, Yu LZ, Zhang Y, Xin DQ, Na YQ, Chen WF. Rapid identification of UCA1 as a very sensitive and specific unique marker for human bladder carcinoma. Clin Cancer Res 2006; 12: 4851-4858.
28. Xie XJ, Li X, Wang F, Chen W. Cellular localization and tissue expression pattern of UCA1, a non-coding RNA. Nan Fang Yi Ke Da Xue Xue Bao 2010; 30: 57-60.
29. Kaneko K, Ito Y, Ono Y, Tainaka T, Tsuchiya H, Shimoyama Y, Ando H. Gene expression profiling reveals upregulated UCA1 and BMF in gallbladder epithelia of children with pancreaticobiliarymaljunction. J Pediatr Gastroenterol Nutr 2011; 52: 744-750.
30. Qiao HP, Gao WS, Huo JX, Yang ZS. Long Non-coding RNA GAS5 Functions as a Tumor Suppressor in Renal Cell Carcinoma. Asian Pac J Cancer Prev 2013; 14: 1077-82.
31. Tsang WP, Wong TW, Cheung AH, Co CN, Kwok TT. Induction of drug resistance and transfor mation in human cancer cells by the noncoding RNA CUDR. RNA 2007; 13: 890-898.
32. Wang F, Li X, Xie X, Zhao L, Chen W. UCA1, a non-protein-coding RNA up-regulated in bladder carcinoma and embryo, influencing cell growth and promoting invasion. FEBS Lett 2008; 582: 1919-1927.
33. Rafiee P, Shi Y, Su J, Pritchard KA Jr, Tweddell JS, Baker JE. Erythropoietin protects the infant heartagainst ischemia-reperfusion injury by triggering multiple signalingpathways. Basic Res Cardiol 2005; 100: 187-197.